Outcome of Board Meeting

September 8, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, 1st Floor, New Trading Ring, Bandra (E), Rotunda Building, P. J. Towers, Mumbai – 400 051 Dalal Street, Fort, Trading Symbol: LXCHEM Mumbai – 400 001 Scrip Code: 543277 Dear Sir / Madam, Sub: Intimation of Leadership Transition – Change in Managing Director & Chief Executive Officer Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that, as part of the Company’s succession planning process and with a view to ensuring an orderly leadership transition and continuity in management, the Board of Directors of Laxmi Organic Industries Limited (“Company”), at its meeting held today, i.e. September 8, 2026, based on the recommendation of the Nomination and Remuneration Committee, inter alia, considered and approved the following matters: a. Planned transition of Dr. Rajan Venkatesh Dr. Rajan Venkatesh (DIN: 10057058), Managing Director & Chief Executive Officer (“MD & CEO”) of the Company, has tendered his resignation from the position of MD & CEO and as a Director of the Company as part of the planned leadership transition and will pursue opportunities outside the Company. His resignation will be effective from the close of business hours on November 13, 2026. Consequent to the above, Dr. Rajan Venkatesh will also cease to be a Key Managerial Personnel and a Member of the Finance Committee and Risk Management Committee of the Company with effect from the same date. The Board has placed on record its sincere appreciation for the valuable contribution, leadership and services rendered by Dr. Rajan Venkatesh during his tenure with the Company and wished him success in his future endeavours. b. Appointment of Mr. Harshvardhan Goenka as successor MD & CEO As part of the Company’s succession planning process and to ensure continuity of leadership, the Board, based on the recommendation of the Nomination and Remuneration Committee, has approved the appointment and re-designation of Mr. Harshvardhan Goenka (DIN: 00020916), presently Executive Director of the Company, as Managing Director & Chief Executive Officer (“MD & CEO”), succeeding Dr. Rajan Venkatesh. Mr. Harshvardhan Goenka’s appointment as MD & CEO will be for a period of five (5) years with effect from November 14, 2026 up to November 13, 2031, subject to the approval of the shareholders of the Company and other applicable statutory/regulatory approvals. Mr. Harshvardhan Goenka will continue on the same remuneration and compensation package as presently approved for him in his capacity as Executive Director, subject to the requisite approvals. The relevant details as required pursuant to Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI circulars are enclosed as Annexure A. A copy of the resignation letter received from Dr. Rajan Venkatesh is enclosed as Annexure B. The press release being issued by the Company in this regard is enclosed as Annexure C. We request you to kindly take the above information on record. Thanking you, For Laxmi Organic Industries Limited Aniket Hirpara Company Secretary and Compliance Officer Annexure A Additional details as required under Regulation 30 of the SEBI Listing Regulations a. Resignation of Dr. Rajan Venkatesh Sr. No. Particulars Remarks 1 Name of the Director Dr. Rajan Venkatesh (DIN: 10057058) 2 Reason for resignation Resignation from the position of Managing Director & Chief Executive Officer and as a Director of the Company to pursue a professional opportunity outside the Company. 3 Date of resignation Effective from the close of business hours on November 13, 2026. 4 Brief Profile Not applicable 5 Disclosure of relationship Not applicable between Directors 6 Other Consequential Dr. Rajan Venkatesh shall also cease to be a Key Managerial cessation Personnel and a Member of the Finance Committee and Risk Management Committee of the Company with effect from the close of business hours on November 13, 2026. b. Appointment/Re-designation of Mr. Harshvardhan Goenka Sr. No. Particulars Remarks 1 Name of the Director Mr. Harshvardhan Goenka (DIN: 00020916) 2 Reason for appointment As part of the Company’s succession planning process, Mr. Harshvardhan Goenka, presently Executive Director, has been appointed and re-designated as Managing Director & Chief Executive Officer, succeeding Dr. Rajan Venkatesh. 3 Date of appointment November 14, 2026 4 Terms of appointment Five (5) years from November 14, 2026 to November 13, 2031, subject to approval of the shareholders and other applicable approvals. 5 Brief Profile Mr. Harshvardhan Goenka has been associated with Laxmi Organic Industries Limited since 2011 and has served on its Board since November 2020. He has played a key role in shaping the Company’s strategic priorities, including capital allocation, mergers and acquisitions, business diversification and sustainable growth. He holds a Bachelor’s degree in Economics and Business Management from Babson College, USA, and is pursuing Executive Education at Harvard Business School. He is also associated with the Indian Chemical Council, Assocham and FICCI. 6 Disclosure of relationship Harshvardhan Goenka is related to Mr. Ravi Goenka (Executive between Directors Chairman) as his Son and to Mr. Rajeev Goenka (Director) as his nephew. Further, he is a member of the Promoter Group. 7 Declaration The Company confirms that Mr. Harshvardhan Goenka is not debarred from holding the office of Director by virtue of any order of SEBI or any other such authority. Annexure B Annexure C Press Release LAXMI ORGANIC INDUSTRIES LIMITED ANNOUNCES PLANNED LEADERSHIP TRANSITION Mumbai, September 8, 2026: Laxmi Organic Industries Limited (“the Company”) today announced a planned leadership transition, pursuant to which Mr. Harshvardhan Goenka will succeed Dr. Rajan Venkatesh as Managing Director & Chief Executive Officer, subject to requisite shareholder and other applicable statutory/regulatory approvals, effective November 14, 2026. The transition forms part of the Company’s succession planning process and is intended to ensure continuity. Dr. Venkatesh, who has served as Managing Director & Chief Executive Officer for the past three and a half years, will step down from the position as part of this planned transition with effect from the close of business hours on November 13, 2026 and will pursue other opportunities. Commenting on the transition, Mr. Ravi Goenka, Executive Chairman, said: “Rajan has been a tremendous asset to Laxmi. His legacy includes empowerment with accountability, a deeply ingrained culture of safety, and a transparent, apolitical and non-layered way of working. He understood the fabric of Laxmi and strengthened it with respect and conviction. We are grateful for his leadership and wish him every success in his future endeavours.” Commenting on the appointment of Mr. Harshvardhan Goenka, Ravi said: “We are delighted that Harsh will assume leadership of Laxmi. He brings a strong understanding of the business, drive and strategic intent needed for the Company’s next phase of growth. We are confident that, together with the management team, he will build on the Company’s strengths and create long-term value for stakeholders.” Dr. Rajan Venkatesh said: “It has been a privilege to work with the Board and lead the Laxmi team in serving its Indian and global customer base. I am pleased that Harsh will succeed me as part of this planned succession process, which provides continuity for all relevant stakeholders. I thank the entire Laxmi team and wish Harsh and the team every success in the journey ahead.” Mr. Harshvardhan Goenka said: “I am deeply honoured by the confidence the Board has placed in me and excited by the opportunity to lead Laxmi into its next chapter. I strongly b [Showing first 8,000 characters — download PDF for full document]